Related references
Note: Only part of the references are listed.Treatment of symptomatic uterine adenomyosis with linzagolix, an oral gonadotrophin-releasing hormone antagonist: a pilot study
Jacques Donnez et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2022)
Origin and Pathogenic Mechanisms of Uterine Adenomyosis: What Is Known So Far
Christina Anna Stratopoulou et al.
REPRODUCTIVE SCIENCES (2021)
Comparison of dienogest versus combined oral contraceptive pills in the treatment of women with adenomyosis: A randomized clinical trial
Ahmed Hassanin et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2021)
Investigation of the role of platelets in the aetiopathogenesis of adenomyosis
Stefania Mosele et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2021)
Ulipristal acetate use in adenomyosis: A randomized controlled trial
Perrine Capmas et al.
JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION (2021)
Long-term durability of uterine artery embolisation for treatment of symptomatic adenomyosis
Jolande Ma et al.
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY (2021)
LncRNA MIR22HG is downregulated in adenomyosis and upregulates miR-2861 through demethylation to inhibit endometrial cell proliferation
Ke Yu et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2021)
Effects of Etonogestrel implants on pelvic pain and menstrual flow in women suffering from adenomyosis or endometriosis Results from a prospective, observational study
Xiaocen Niu et al.
MEDICINE (2021)
Progression of adenomyosis magnetic resonance imaging features under ulipristal acetate for symptomatic fibroids
Lisa Calderon et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2021)
Talin1 Induces Epithelial-Mesenchymal Transition to Facilitate Endometrial Cell Migration and Invasion in Adenomyosis Under the Regulation of microRNA-145-5p
Yi-yi Wang et al.
REPRODUCTIVE SCIENCES (2021)
Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review
Jacques Donnez et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Uterine Adenomyosis: From Disease Pathogenesis to a New Medical Approach Using GnRH Antagonists
Jacques Donnez et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)
Identifying Common Pathogenic Features in Deep Endometriotic Nodules and Uterine Adenomyosis
Christina Anna Stratopoulou et al.
JOURNAL OF CLINICAL MEDICINE (2021)
A clinical observational study on the efficacy of subcutaneous etonogestrel implants for adenomyosis in 20 patients
Lekai Nie et al.
GYNECOLOGICAL ENDOCRINOLOGY (2021)
P–299 Efficacy and safety of linzagolix for the treatment of severe adenomyosis: Initial results from a pilot study
O Donnez et al.
HUMAN REPRODUCTION (2021)
Upregulated microRNA let-7a accelerates apoptosis and inhibits proliferation in uterine junctional zone smooth muscle cells in adenomyosis under conditions of a normal activated hippo-YAP1 axis
Jun-Hua Huang et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2021)
Reductions in endometriosis-associated pain among women treated with elagolix are consistent across a range of baseline characteristics reflective of real-world patients
Mauricio S. Abrao et al.
BMC WOMENS HEALTH (2021)
Relugolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, in women with endometriosis-associated pain: phase 2 safety and efficacy 24-week results
Yutaka Osuga et al.
BMC WOMENS HEALTH (2021)
Ultra-Long GnRH Agonist Protocol During IVF/ICSI Improves Pregnancy Outcomes in Women With Adenomyosis: A Retrospective Cohort Study
Jie Lan et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Adenomyosis incidence, prevalence and treatment: United States population-based study 2006-2015
Onchee Yu et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2020)
Long-term use of dienogest for the treatment of primary and secondary dysmenorrhea
Yutaka Osuga et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2020)
Exploring the challenges for a new classification of adenomyosis
Marwan Habiba et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2020)
Long-term efficacy and feasibility of levonorgestrel-releasing intrauterine device use in patients with adenomyosis
Soo Youn Song et al.
MEDICINE (2020)
Gonadotropin-releasing hormone antagonist (linzagolix): a new therapy for uterine adenomyosis
Olivier Donnez et al.
FERTILITY AND STERILITY (2020)
Gonadotropin-releasing hormone antagonist linzagolix: possible treatment for assisted reproduction patients presenting with adenomyosis and endometriosis?
Andrea Borini et al.
FERTILITY AND STERILITY (2020)
Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone-antagonist: a randomized clinical trial
Jacques Donnez et al.
FERTILITY AND STERILITY (2020)
Hormone therapy for intramural myoma-related infertility from ulipristal acetate to GnRH antagonist: a review
Donnez Jacques et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2020)
The effect of adenomyosis on IVF after long or ultra-long GnRH agonist treatment
Xiaoni Hou et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2020)
The Interplay Between Prolactin and Reproductive System: Focus on Uterine Pathophysiology
Renata S. Auriemma et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
What if deep endometriotic nodules and uterine adenomyosis were actually two forms of the same disease?
Jacques Donnez et al.
FERTILITY AND STERILITY (2019)
Vaginal bromocriptine improves pain, menstrual bleeding and quality of life in women with adenomyosis: A pilot study
Johanna K. Andersson et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2019)
Reproductive, obstetric, and perinatal outcomes of women with adenomyosis and endometriosis: a systematic review and meta-analysis
Joanne Horton et al.
HUMAN REPRODUCTION UPDATE (2019)
Elasticity of adenomyosis is increased after GnRHa therapy and is associated with spontaneous pregnancy in infertile patents
Meng Xie et al.
JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION (2019)
Short- and long-term impact of gonadotropin-releasing hormone analogue treatment on bone loss and fracture
May-Tal Sauerbrun-Cutler et al.
FERTILITY AND STERILITY (2019)
Subtype I (intrinsic) adenomyosis is an independent risk factor for dienogest-related serious unpredictable bleeding in patients with symptomatic adenomyosis
Sho Matsubara et al.
SCIENTIFIC REPORTS (2019)
Ulipristal acetate therapy increases ultrasound features of adenomyosis: a good treatment given in an erroneous diagnosis of uterine fibroids
Francesca Conway et al.
GYNECOLOGICAL ENDOCRINOLOGY (2019)
Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding
Magdalena Bofill Rodriguez et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2019)
Role of medical therapy in the management of uterine adenomyosis
Silvia Vannuccini et al.
FERTILITY AND STERILITY (2018)
Introduction: Uterine adenomyosis, another enigmatic disease of our time
Jacques Donnez et al.
FERTILITY AND STERILITY (2018)
Uterine adenomyosis and adenomyoma: the surgical approach
Hisao Osada
FERTILITY AND STERILITY (2018)
Ulipristal Acetate Improves Clinical Symptoms in Women with Adenomyosis and Uterine Myomas
Meritxell Gracia et al.
JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY (2018)
Treatment of Adenomyosis with Subcutaneous Etonogestrel Implants: A Clinical Observational Study in 17 Patients
Jianbo Wu et al.
MEDICAL SCIENCE MONITOR (2018)
Progesterone Receptor Status Predicts Response to Progestin Therapy in Endometriosis
Valerie A. Flores et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Endometrial changes during ulipristal acetate use: A systematic review
Inge De Milliano et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2017)
Evaluation of the efficacy and safety of dienogest in the treatment of painful symptoms in patients with adenomyosis: a randomized, double-blind, multicenter, placebo-controlled study
Yutaka Osuga et al.
FERTILITY AND STERILITY (2017)
Effects of adenomyosis on in vitro fertilization treatment outcomes: a meta-analysis
Grace Younes et al.
FERTILITY AND STERILITY (2017)
Long-term use of dienogest in the treatment of painful symptoms in adenomyosis
Yutaka Osuga et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2017)
Uterine Artery Embolization for the Treatment of Adenomyosis: A Systematic Review and Meta-Analysis
Annefleur M. de Bruijn et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2017)
Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist
H. S. Taylor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
MicroRNA-17 downregulates expression of the PTEN gene to promote the occurrence and development of adenomyosis
Haiyan Hu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
Safety of medical treatments for endometriosis
Nicola Berlanda et al.
EXPERT OPINION ON DRUG SAFETY (2016)
GnRH and GnRH receptors in the pathophysiology of the human female reproductive system
Roberto Maggi et al.
HUMAN REPRODUCTION UPDATE (2016)
Estrogen-progestins and progestins for the management of endometriosis
Paolo Vercellini et al.
FERTILITY AND STERILITY (2016)
Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis
Xishi Liu et al.
HUMAN REPRODUCTION (2016)
Anti-platelet therapy holds promises in treating adenomyosis: experimental evidence
Bo Zhu et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2016)
Global Transcriptome Abnormalities of the Eutopic Endometrium From Women With Adenomyosis
Christopher N. Herndon et al.
REPRODUCTIVE SCIENCES (2016)
Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial
Omar M. Shaaban et al.
CONTRACEPTION (2015)
What we know about primary dysmenorrhea today: a critical review
Stella Iacovides et al.
HUMAN REPRODUCTION UPDATE (2015)
Efficacy of dienogest in the treatment of symptomatic adenomyosis: a pilot study
Tetsuya Hirata et al.
GYNECOLOGICAL ENDOCRINOLOGY (2014)
Elagolix Treatment for Endometriosis-Associated Pain: Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
Michael P. Diamond et al.
REPRODUCTIVE SCIENCES (2014)
Effects of the levonorgestrel-releasing intrauterine system on urinary symptoms in patients with adenomyosis
Murat Ekin et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2013)
Long-term pituitary downregulation before frozen embryo transfer could improve pregnancy outcomes in women with adenomyosis
Zhihong Niu et al.
GYNECOLOGICAL ENDOCRINOLOGY (2013)
Improvement in chronic pelvic pain after gonadotropin releasing hormone analogue (GnRH-a) administration in premenopausal women suffering from adenomyosis or endometriosis: a retrospective study
Michele Morelli et al.
GYNECOLOGICAL ENDOCRINOLOGY (2013)
Aromatase inhibitors or gonadotropin-releasing hormone agonists for the management of uterine adenomyosis: a randomized controlled trial
Ahmed M. Badawy et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2012)
Four subtypes of adenomyosis assessed by magnetic resonance imaging and their specification
Yohei Kishi et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2012)
The distribution of immune cells and macrophages in the endometrium of women with recurrent reproductive failure. II: adenomyosis and macrophages
Kelton P. Tremellen et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2012)
The regulation of embryo implantation and endometrial decidualization by progesterone receptor signaling
Michael J. Large et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Ulipristal Acetate versus Placebo for Fibroid Treatment before Surgery
Jacques Donnez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Fertility outcome of infertile women with adenomyosis treated with the combination of a conservative microsurgical technique and GnRH agonist: Long-term follow-up in a series of nine patients
Ben-Shian Huang et al.
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2012)
Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis
Ozlem Ozdegirmenci et al.
FERTILITY AND STERILITY (2011)
Surgical procedure to conserve the uterus for future pregnancy in patients suffering from massive adenomyosis
Hisao Osada et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2011)
Conservative surgical management for diffuse uterine adenomyosis
Masato Nishida et al.
FERTILITY AND STERILITY (2010)
The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis
Jie Sheng et al.
CONTRACEPTION (2009)
Absence of aromatase protein and mRNA expression in endometriosis
S. Colette et al.
HUMAN REPRODUCTION (2009)
Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis
SiHyun Cho et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2008)
Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging
Aristides M. Bragheto et al.
CONTRACEPTION (2007)
The endometriosis syndromes: a clinical classification in the presence of aetiological confusion and therapeutic anarchy
R Garry
HUMAN REPRODUCTION (2004)
MR imaging of diffuse adenomyosis changes after GnRH analog therapy
I Imaoka et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2002)
A single mid-follicular dose of CDB-2914, a new antiprogestin, inhibits folliculogenesis and endometrial differentiation in normally cycling women
P Stratton et al.
HUMAN REPRODUCTION (2000)
Share Paper
